UNSPSC 51285303: Nifurquinazol

This classification denotes an antimicrobial with the molecular formula C16H16N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 44E5RRL600, chemically known as 2,2-((2-(5-nitro-2-furyl)-4-quinazolinyl)imino)diethanol but more generally known as nifurquinazol, which bears US NIH Compound Identifier 21139. European Medicines Agency schedules Nifurquinazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09276MIG.

UNSPSC 51285303 Nifurquinazol, a Commodity code, shows limited recent state and local procurement activity directly aligned with the code's nominal scope. The three recent solicitations tagged to this code — from Seminole County, Florida; Texas Health and Human Services Commission; and the City of Tampa — involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and medical and first aid supplies for emergency response, none of which clearly map to nifurquinazol procurement. State and local governments do use medical and pharmaceutical commodity codes to procure emergency health supplies, OTC products, and controlled-distribution pharmaceuticals, but the recent opportunities under this specific code do not demonstrate meaningful activity in nifurquinazol itself. The issuing bodies posting under this code span county health departments, state HHS commissions, municipal fire departments, and cooperative purchasing alliances representing multiple jurisdictions.

Geographic activity appears concentrated in Florida and Texas based on recent posts, with cooperative purchasing vehicles such as MMCAP (Minnesota Multistate Cooperative Purchasing Alliance) extending reach across multiple states including Oregon and Minnesota. Representative recent opportunities include Seminole County's IFB 60459723LAS (due Jul 26, 2023) for naloxone and drug deactivation systems with annual quantities of 1,900 and 800 units respectively; the City of Tampa's Bid 26-P-00145 (due Mar 13, 2026) for medical and first aid supplies estimated at $700,000 and reserved for certified Small Local Business Enterprises; and MMCAP's RFP S1070000015802 (due Mar 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. The code itself demonstrates minimal recent procurement volume in nifurquinazol specifically, warranting clarification with issuing bodies on whether their actual procurements align with this code's assignment.